| Genetic variants associated with phenytoin-related severe cutaneous adverse reactions WH Chung, WC Chang, YS Lee, YY Wu, CH Yang, HC Ho, MJ Chen, ... Jama 312 (5), 525-534, 2014 | 312 | 2014 |
| Inhibition of the interleukin-36 pathway for the treatment of generalized pustular psoriasis H Bachelez, SE Choon, S Marrakchi, AD Burden, TF Tsai, A Morita, ... New England Journal of Medicine 380 (10), 981-983, 2019 | 283 | 2019 |
| Clinical profile, morbidity, and outcome of adult‐onset generalized pustular psoriasis: analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia SE Choon, NM Lai, NA Mohammad, NM Nanu, KE Tey, SF Chew International journal of dermatology 53 (6), 676-684, 2014 | 265 | 2014 |
| Trial of spesolimab for generalized pustular psoriasis H Bachelez, SE Choon, S Marrakchi, AD Burden, TF Tsai, A Morita, ... New England Journal of Medicine 385 (26), 2431-2440, 2021 | 233 | 2021 |
| Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional study AS Paller, K Mercy, MJ Kwasny, SE Choon, KM Cordoro, G Girolomoni, ... JAMA dermatology 149 (2), 166-176, 2013 | 232 | 2013 |
| Clinical and genetic differences between pustular psoriasis subtypes S Twelves, A Mostafa, N Dand, E Burri, K Farkas, R Wilson, HL Cooper, ... Journal of allergy and clinical immunology 143 (3), 1021-1026, 2019 | 224 | 2019 |
| AP1S3 mutations are associated with pustular psoriasis and impaired Toll-like receptor 3 trafficking N Setta-Kaffetzi, MA Simpson, AA Navarini, VM Patel, HC Lu, MH Allen, ... The American Journal of Human Genetics 94 (5), 790-797, 2014 | 215 | 2014 |
| Rare pathogenic variants in IL36RN underlie a spectrum of psoriasis-associated pustular phenotypes N Setta-Kaffetzi, AA Navarini, VM Patel, V Pullabhatla, AE Pink, SE Choon, ... The Journal of investigative dermatology 133 (5), 1366, 2013 | 189 | 2013 |
| Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study SK Mahil, N Dand, KJ Mason, ZZN Yiu, T Tsakok, F Meynell, B Coker, ... Journal of allergy and clinical immunology 147 (1), 60-71, 2021 | 177 | 2021 |
| AP1S3 mutations cause skin autoinflammation by disrupting keratinocyte autophagy and up-regulating IL-36 production SK Mahil, S Twelves, K Farkas, N Setta-Kaffetzi, AD Burden, JE Gach, ... Journal of Investigative Dermatology 136 (11), 2251-2259, 2016 | 160 | 2016 |
| IL36RN mutations define a severe autoinflammatory phenotype of generalized pustular psoriasis S Hussain, DM Berki, SE Choon, AD Burden, MH Allen, JI Arostegui, ... Journal of Allergy and Clinical Immunology 135 (4), 1067-1070. e9, 2015 | 146 | 2015 |
| Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia WY Ding, CK Lee, SE Choon International journal of dermatology 49 (7), 834-841, 2010 | 140 | 2010 |
| Activating CARD14 mutations are associated with generalized pustular psoriasis but rarely account for familial recurrence in psoriasis vulgaris DM Berki, L Liu, SE Choon, AD Burden, CEM Griffiths, AA Navarini, ... Journal of Investigative Dermatology 135 (12), 2964-2970, 2015 | 134 | 2015 |
| Association of HLA-B* 15: 13 and HLA-B* 15: 02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population CC Chang, CC Ng, CL Too, SE Choon, CK Lee, WH Chung, SH Hussein, ... The pharmacogenomics journal 17 (2), 170-173, 2017 | 111 | 2017 |
| An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia SE Choon, NM Lai Indian Journal of Dermatology, Venereology and Leprology 78, 734, 2012 | 92 | 2012 |
| Clinical course and characteristics of generalized pustular psoriasis SE Choon, AA Navarini, A Pinter American Journal of Clinical Dermatology 23 (Suppl 1), 21-29, 2022 | 91 | 2022 |
| IL-36 promotes systemic IFN-I responses in severe forms of psoriasis M Catapano, M Vergnano, M Romano, SK Mahil, SE Choon, AD Burden, ... Journal of Investigative Dermatology 140 (4), 816-826. e3, 2020 | 82 | 2020 |
| The medication risk of Stevens–Johnson syndrome and toxic epidermal necrolysis in asians: the major drug causality and comparison with the US FDA label YH Wang, CB Chen, W Tassaneeyakul, Y Saito, M Aihara, SE Choon, ... Clinical Pharmacology & Therapeutics 105 (1), 112-120, 2019 | 77 | 2019 |
| Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis … SE Choon, MG Lebwohl, S Marrakchi, AD Burden, TF Tsai, A Morita, ... BMJ open 11 (3), e043666, 2021 | 74 | 2021 |
| Analysis of the Leprosy Agents Mycobacterium leprae and Mycobacterium lepromatosis in Four Countries XY Han, FM Aung, SE Choon, B Werner American journal of clinical pathology 142 (4), 524-532, 2014 | 72 | 2014 |
